Stocks Health care GEHC
NASDAQ · Health careGE HealthCare Technologies Inc. (GEHC)
GE HealthCare Technologies Inc. brought in $21.6B of revenue over the twelve months to September 30, 2026, up 6.9% from a year earlier. Net income was $2.2B, a net margin of 10.0%. Operating cash flow minus capital spending left $1.5B of free cash flow in fiscal 2025. At September 30, 2026 it held $2.8B in cash against $10B of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on October 28, 2026.
Key facts about GE HealthCare Technologies Inc.
- Net worth
- GE HealthCare Technologies Inc. has a market value (market cap) of $37.8B at the latest share price, and shareholders' equity of $11.6B on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2025 revenue was $20.6B (+4.8% year on year), with net income of $2.1B. Over the 12 months to September 30, 2026: revenue $21.6B, net income $2.2B.
- Cash flow
- In fiscal 2025 operations brought in $2B of cash; after $482M of capital spending, free cash flow was $1.5B.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on October 28, 2026 and covers the period to September 30, 2026. Open on SEC EDGAR
- Next earnings report
- GE HealthCare Technologies Inc.'s next report is expected around February 3, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
- Dividend
- GE HealthCare Technologies Inc. declared dividends of $0.14 per share in fiscal 2025, a yield of 0.17% at the current price.
What GE HealthCare Technologies Inc. does
GE HealthCare Technologies Inc. is registered with the SEC under industry code SIC 3844 (X-Ray Apparatus & Tubes & Related Irradiation Apparatus). Its shares trade on NASDAQ under the ticker GEHC.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $20.6B | $2.1B | $4.55 | $1.5B |
| 2024 | $19.7B | $2B | $4.34 | $1.6B |
| 2023 | $19.6B | $1.6B | $3.03 | $1.7B |
| 2023 | $18.3B | $1.9B | $4.22 | $1.8B |
| 2021 | $17.6B | $2.2B | $4.95 | $1.4B |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where GEHC ranks in Health care
Dividends
GE HealthCare Technologies Inc. declared $0.14 per share in fiscal 2025. At the current price that is a yield of 0.17%. It paid out $64M in cash dividends, 3% of its net income.
| Fiscal year | Per share | Paid out | Of profit |
|---|---|---|---|
| 2025 | $0.14 | $64M | 3% |
| 2024 | $0.13 | $55M | 3% |
| 2023 | $0.12 | $41M | 3% |
| 2023 | n/a | $0 | 0% |
| 2021 | n/a | $0 | 0% |
Latest SEC filings
What GE HealthCare Technologies Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- November 5, 2026
- October 28, 2026Quarterly report 10-Q · period to September 30, 2026Revenue rose 7.2% to $5.5B versus the same quarter last year; diluted EPS $1.36 versus $0.98.
- October 28, 2026
- September 22, 2026Executive or director change8-KGE HealthCare appointed AT&T Chief Financial Officer Pascal Desroches to its Board of Directors, effective January 4, 2027.
- August 18, 2026
- August 7, 2026Passive stake changed SCHEDULE 13G/A
- August 7, 2026Passive stake changed SCHEDULE 13G/A
- July 29, 2026
- July 29, 2026Quarterly report 10-Q · period to June 30, 2026Revenue rose 5.8% to $5.3B versus the same quarter last year; diluted EPS $1.24 versus $1.06.
- July 29, 2026
What is GEHC worth? A DCF from its reported cash flow
Insider trades
What the people running GE HealthCare Technologies Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider bought or sold shares on the open market in the last 90 days. The 22 reported changes were pay in shares, option exercises, shares withheld for tax or gifts.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| September 14, 2026 | Grogan William KChief Financial Officer | Received as pay | 62,256 | - |
| September 14, 2026 | Grogan William KChief Financial Officer | Received as pay | 12,840 | - |
| September 3, 2026 | Arduini Peter JPresident and CEO, Director | Shares withheld for tax | 6,303 | $444.7K |
| September 3, 2026 | Jimenez Frank RGC & Corporate Secretary | Shares withheld for tax | 1,480 | $104.4K |
| September 3, 2026 | Holton Adam YChief People Officer | Shares withheld for tax | 673 | $47.5K |
| September 3, 2026 | O'Neill Kevin MichaelCEO, PDx | Shares withheld for tax | 718 | $50.7K |
| September 3, 2026 | Newcomb George A.Chief Accounting Officer | Shares withheld for tax | 112 | $7.9K |
| September 3, 2026 | Kass-Hout TahaChief Technology Officer | Shares withheld for tax | 1,502 | $106K |
Who owns GEHC
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Dodge & Cox13G, passive | 10.5% | August 7, 2026 |
| Vanguard Capital Management13G, passive | 7.31% | April 29, 2026 |
Largest institutional holders
Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 1,224 managers reported a position.
| Holder | Shares | Change on quarter |
|---|---|---|
| Dodge & Cox | 37,864,164 | +6,552,100 |
| BlackRock, Inc. | 37,467,843 | +1,483,516 |
| Vanguard Capital Management LLC | 29,724,359 | +860,171 |
| State Street Corp | 20,861,566 | +323,090 |
| Vanguard Portfolio Management LLC | 20,275,526 | +1,092,369 |
| Invesco Ltd. | 18,296,350 | +992,911 |
| Harris Associates L P | 15,329,664 | -265,324 |
| Barrow Hanley Mewhinney & Strauss LLC | 13,455,814 | +1,571,226 |
| Geode Capital Management, LLC | 12,871,800 | +472,165 |
| Hotchkis & Wiley Capital Management LLC | 12,250,502 | +2,282,629 |
| Jpmorgan Chase & Co | 10,329,164 | +1,364,495 |
| Morgan Stanley | 6,223,322 | -417,801 |
| Norges Bank | 5,823,524 | new |
| Dimensional Fund Advisors LP | 5,401,410 | +1,971 |
| Boston Partners | 5,153,347 | +55,647 |
| Van Eck Associates Corp | 4,482,631 | +177,028 |
| Goldman Sachs Group Inc | 4,446,565 | +1,180,427 |
| Northern Trust Corp | 3,938,748 | -113,317 |
| Bank of America Corp | 3,249,771 | -882,969 |
| Fmr LLC | 3,155,095 | +379,982 |
Insiders
19 insiders reported holding 1,059,831 shares in total, about $88.6M at the last price.
| Holder | Shares |
|---|---|
| Arduini Peter JPresident and CEO, Director | 241,606 |
| Culp H Lawrence JrDirector | 171,649151,207 held indirectly |
| Jimenez Frank RGC & Corporate Secretary | 89,321 |
| Kass-Hout TahaChief Technology Officer | 88,467 |
| Saccaro JamesChief Financial Officer | 87,471 |
| Grogan William KChief Financial Officer | 75,096 |
| Rackliffe PhilipCEO, AIS | 41,533 |
| Rott RolandCEO, Imaging | 41,082 |
| Bankes JeannetteCEO, Patient Care Solutions | 37,293 |
| O'Neill Kevin MichaelCEO, PDx | 32,026 |
Questions about GEHC
What does GE HealthCare Technologies Inc. do?
GE HealthCare Technologies Inc. is a company in the Health care sector, listed on NASDAQ as GEHC. Its shares trade on NASDAQ under the ticker GEHC.
What is GE HealthCare Technologies Inc.'s net worth?
GE HealthCare Technologies Inc. has a market value (market cap) of $37.8B at the latest share price, and shareholders' equity of $11.6B on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is GE HealthCare Technologies Inc. profitable?
Yes. Over the twelve months to September 30, 2026 it reported net income of $2.2B on revenue of $21.6B, a net margin of 10.0%.
How much revenue does GE HealthCare Technologies Inc. make?
Over the twelve months to September 30, 2026 GE HealthCare Technologies Inc. reported revenue of $21.6B. That is 6.9% more than a year earlier.
When did GE HealthCare Technologies Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on October 28, 2026. It covers the period to September 30, 2026. Its newest filing of any kind is the executive or director change from November 5, 2026.
When is GE HealthCare Technologies Inc.'s next earnings report?
GE HealthCare Technologies Inc.'s next report is expected around February 3, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
Does GE HealthCare Technologies Inc. pay a dividend?
Yes. GE HealthCare Technologies Inc. declared dividends of $0.14 per share in fiscal 2025, a yield of 0.17% at the current price.
Similar companies
Compare GEHC with
Follow GEHC
Get an email when GE HealthCare Technologies Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values GE HealthCare Technologies Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.